Prevalence of dispensing compounded formulations based on plant active ingredients to reduce body weight in a pharmacy in the Municipality of Cascavel, State of Paraná (PR), Brazil
DOI:
https://doi.org/10.33448/rsd-v13i11.47389Keywords:
Obesity; Plant extract; Phytotherapy; Prevalence.Abstract
Overweight and obesity, affecting about 60% of the adult population in Brazil, represent a growing public health issue. Driven by aesthetic standards, many people seek quick weight loss methods, resorting to diets and substances without professional guidance. In this context, plant-based compounds such as berberine, horsetail, garcinia, and morosil have gained prominence in compounded formulations for weight control due to their metabolic, lipolytic, antioxidant, and diuretic properties. This article aims to provide information about the products most demanded by the population and promote awareness about the rational use of weight loss formulations. This study analyzed the prevalence and composition of compounded formulations based on plant-based compounds in a pharmacy in the Municipality of Cascavel-PR, with dispensing data from January to December 2023. Among the 25 compounds evaluated, berberine was the most used (20.71%), and caffeine was the least frequent (3.0%). A seasonal demand was observed, with peaks in June and December, possibly influenced by cultural factors, and nutritionists were responsible for 51.52% of the dispensations. The analysis suggests that the high use of certain compounds reflects both market trends and patients' perceptions of these components' efficacy. However, using plant-based compounds without guidance can result in unwanted effects, underscoring the need for awareness of safe usage based on scientific evidence and professional supervision.
References
Brasil, Ministério da Saúde. (2021). Excesso de peso e obesidade. Gov.br. https://www.gov.br/saude/pt-br/assuntos/obesidade.
Brasil, Ministério da Saúde. (2022). O impacto da obesidade. Gov.br. https://www.gov.br/saude/pt-br.
Chong, P.-W., et al. (2014). A review of the efficacy and safety of Litramine IQP-G-002AS, an Opuntia ficus-indica derived fiber for weight management. Evidence-based Complementary and Alternative Medicine: eCAM, 2014. https://nih.gov/ECAM2014-943713.pdf.
Cruz, C. K. S., et al. (2020). O uso de plantas medicinais no tratamento da obesidade: revisão integrativa. Research, Society and Development, 9(9), e439997167-e439997167. https://rsdjournal.org/index.php/rsd/article/view/7167/6607.
DiNicolantonio, J. J., Bhat, A. G., & Okeefe, J. (2020). Effects of spirulina on weight loss and blood lipids: a review. Open Heart, 7(1), e001003. https://bmj.com.
Fonseca, B. K. D., Silva, J. S. da, Silva, G. C. C., Rahal, I. L., Laginistra, B. de F. A., Gazim, Z. C., & Junior, R. P. (2022). Alternativas fitoterápicas no controle da obesidade. Arquivos de Ciências da Saúde da UNIPAR, 26(3), 1163-1190.
Gil, A. C. (2008). Métodos e técnicas de pesquisa social. [s.l.]: [s.n.]. https://ayanrafael.com/wp-content/uploads/2011/08/gil-a-c-mc3a9todos-e-tc3a9cnicas-de-pesquisa-social.pdf.
Kaats, G. R., Bagchi, D., & Preuss, H. G. (2015). Konjac glucomannan dietary supplementation causes significant fat loss in compliant overweight adults. Journal of the American College of Nutrition, 0(0), 1-7. https://researchgate.net.
Kreider, R. B., et al. (2010). ISSN exercise & sport nutrition review: research & recommendations. Journal of the International Society of Sports Nutrition, 7(1). https://nih.gov.
Lima, L. P., & De Paula Barbosa, A. (2021). A review of the lipolytic effects and the reduction of abdominal fat from bioactive compounds and moro orange extracts. Heliyon, 7(8), e07695.
Lucas, R. R., et al. (2016). Fitoterápicos aplicados à obesidade. DEMETRA: Alimentação, Nutrição & Saúde, 11(2), 473–92.
https://doi.org/10.12957/demetra.2016.19154.
Och, A., Podgórski, R., & Nowak, R. (2020). Biological activity of berberine—A summary update. Toxins, 12(11), 713. https://nih.gov.
Oliveira, A. M. C. de, Silva, I. C., & Sousa, J. A. de S. (2021). Análise crítica da formulação do Morosil e sua comercialização no tratamento da obesidade. Research, Society and Development, 10(6), e16910615616.
Onakpoya, I., et al. (2011). The use of garcinia extract (hydroxycitric acid) as a weight loss supplement: A systematic review and meta-analysis of randomised clinical trials. Journal of Obesity, 2011, 1–9.
Organização Mundial da Saúde. (2024). Obesidade e sobrepeso.Who.int. https://www.who.int.
Palheta, R. A., & Freitas, F. M. N. de O. (2022). Integrative review on medicinal plants in the treatment of obesity and dyslipidemias on climacteric women. Research, Society and Development, 11(15), e283111537153. https://doi.org/10.33448/rsd-v11i15.37153.
Pereira A. S. et al. (2019). Didática geral [free e-book]. Santa Maria/RS: UFSM, NTE, 2019.
Silva, M. A., et al. (2021). Opuntia ficus-indica (L.) Mill.: A multi-benefit potential to be exploited. Molecules, 26(4), 951. https://nih.gov.
Suntar, I., et al. (2018). An overview on Citrus aurantium L.: Its functions as food ingredient and therapeutic agent. Oxidative Medicine and Cellular Longevity, 2018.
Vasconcelos, R. B. (2022). Obesidade e fitoterapia. Niceplac. https://uniceplac.edu.br.
Verrengia, E. C., Kinoshita, S. A. T., & Amadei, J. L. (2015). Medicamentos fitoterápicos no tratamento da obesidade. UNICIÊNCIAS. https://uniciencias.pgsscogna.com.br.
Vieira, A. R. R., & Medeiros, P. R. M. da S. (2019). A utilização de fitoterápicos no tratamento da obesidade. Revista Científica da Escola Estadual de Saúde Pública de Goiás “Cândido Santiago”. https://esap.go.gov.br.
VIGITEL. (2019). Vigilância de fatores de risco e proteção para doenças crônicas por inquérito telefônico. https://abeso.org.br/wp-content/uploads/2021/07/vigitel_brasil_2019_vigilancia_fatores_risco-1-2.pdf.
Zhang, Z., et al. (2014). Berberine activates thermogenesis in white and brown adipose tissue. Nature Communications, 5(1).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Emily Hermogene de Oliveira; Clarissa Vasconcelos de Oliveira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
